StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Fate Therapeutics (FATE) PT Raised to $20 at Piper Jaffray
March 6, 2018 3:31 AM
Piper Jaffray raised its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
H.C. Wainwright Downgrades Fate Therapeutics (FATE) to Neutral
March 6, 2018 7:57 AM
Fate Therapeutics (FATE) PT Raised to $18 at Wells Fargo
March 6, 2018 7:33 AM
Fate Therapeutics (FATE) PT Raised to $19 at Wedbush
March 6, 2018 6:40 AM
Fate Therapeutics (FATE) PT Raised to $16 at Leerink Partners; 'IPSC Platform Key Value Driver'
March 6, 2018 5:27 AM
Fate Therapeutics (FATE) PT Raised to $20 at BMO Capital; 'Enthusiasm for Cell Therapies Probably Justified'
March 6, 2018 1:13 AM
